期刊文献+

血管性血友病因子与肺栓塞的研究进展 被引量:2

Research progress of von Willebrand factor and pulmonary embolism
下载PDF
导出
摘要 肺栓塞(pulmonary embolism,PE)是我国发病率及死亡率较高的疾病,其形成机制主要为血流动力学改变、气体交换障碍、慢性血栓栓塞性肺动脉高压等。血管性血友病因子(von Willebrand factor,v WF)是在A型血友病中发现的血浆蛋白,为巨核细胞和内皮细胞中合成的一种具有粘附功能的大分子糖蛋白;随着对v WF研究的深入,发现其在出凝血疾病及凝血过程中具有一定作用。作者就v WF与PE的研究进展进行综述。 Pulmonary embolism (PE) is a high incidence of morbidity and mortality in China. The mechanism of PE mainly includes hemodynamic changes, gas exchange barriers, chronic thromboembolic pulmonary hypertension, etc. von Willebrand factor (vWF) is a plasma protein which was found in type A hemophilia. It is a macromolecular glycoprotein with adhesion function synthesized in megakaryocytes and endothelial cells. With the deepening of the research on vWF, we found it has a certain role in the coagulation disease and coagulation process. This review summarizes the progress of vWF and PE.
作者 周贤 袁开芬 赵国厚 ZHOU Xian;YUAN Kaifen;ZHAO Guohou(Department of Respiratory, the Second Affiliated Hospital of KunmingMedical University, Kunming Yunnan 650101, China)
出处 《转化医学杂志》 2019年第1期62-64,共3页 Translational Medicine Journal
关键词 血管性血友病因子 肺栓塞 凝血 von Willebrand factor(vWF) Pulmonary embolism (PE) Clotting
  • 相关文献

参考文献7

二级参考文献78

  • 1孙葵葵,王辰,古力夏提,罗琴.深静脉血栓形成的危险因素及临床分析[J].中华结核和呼吸杂志,2004,27(11):727-730. 被引量:82
  • 2李龙芸,路刚.肺动脉栓塞25例临床分析[J].中华内科杂志,1993,32(9):583-586. 被引量:20
  • 3任宁,黄体钢,舒珺,杜纪兵,倪燕平,周丽娟,张梅,丛洪良,李玉明.急性冠脉综合征患者血清hs-CRP和IL-6水平变化及预后意义[J].武警医学院学报,2007,16(5):497-500. 被引量:5
  • 4程显声,Pulmonary embolism,1994年,25页
  • 5程显声,肺血管疾病学,1993年,179页
  • 6Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25 - year population - based study[ J]. Arch Intern Med, 1998,158 (6) :585 - 593.
  • 7Merten M, Thiagarajan P. P - selectin in arterial thrombosis [ J ]. Z Kardiol, 2004,93 ( 11 ) :855 - 863.
  • 8Yamamoto J, Kovacs IB. Shear - induced in - vitro haemostasis/thrombosis tests: the benefit of using native blood[ J]. Blood Coagulation & Fibrinulysis, 2003,14(8) :697 -702.
  • 9Ikeda Y, Handa M, Murata M, et al. A new approach to antiplatelet therapy : inhibitor of GP Ⅰ b/Ⅴ/Ⅸ - vWF interaction [ J ]. Haemostasis ,2000,30 ( suppl 3 ) :44 - 52.
  • 10Deckmyn H, Cauwenberghs N, Wu D, et al. Development of antibodies that interfere with the collagen - VWF - GPIb axis as new antithrombotics[ J]. Verh K Acad Geneeskd Belg,2005,67 (1) :55 -65.

共引文献342

同被引文献31

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部